NCT04859621View on ClinicalTrials.gov

Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 8, 2021

Primary Completion Date

April 30, 2025

Study Completion Date

July 30, 2025

Conditions
Recurrent Urinary Tract Infection
Interventions
DRUG

Vitamin D3 4000 IU

Oral administration, 2 tablet per time, qd, oral administration with the first meal, continuous use for 48 weeks

DRUG

Vitamin D3 2000 IU

Oral administration, 1 tablet of each per time, qd, oral administration with the first meal, continuous use for 48 weeks

DRUG

Placebo

Oral administration, 2 tablet per time, qd, oral administration with the first meal, continuous use for 48 weeks

OTHER

standard antibiotic therapy

standard antibiotic therapy

Trial Locations (6)

200025

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

Unknown

RECRUITING

The First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an

RECRUITING

Shanghai Oriental Hospital, Shanghai

RECRUITING

The Fifth People's Hospital, Shanghai, Shanghai

RECRUITING

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine，Chongming Branch, Shanghai

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

All Listed Sponsors
lead

Zensun Sci. & Tech. Co., Ltd.

INDUSTRY